You are on page 1of 6

30

Daftar Pustaka

1. Kunti V, Brbori J, Antunovi H, et al. Evaluating the bioactive effects of


flavonoid hesperidin – A new literature data survey. Vojnosanit Pregl 2014;
71(1): 60–65.

2. Srirangam R, Majumdar S. Solubility, Stability, Physicochemical characteristics


and In Vitro Ocular Tissue Permeability of Hesperidin: a Natural Bioflavonoid.
Pharm Res. 2009 ; 26(5): 1217–1225.

3. Siddique S, Firdous S, Durrani A, et al. Hesperidin, a citrus flavonoid, increases


the bioavailability of micronutrients of Gallus domesticus (chicken) eggshell: in
vitro study. J Chemical Speciation & Bioavailability, 2016; 28:1-4, 88-94.

4. Bossacoma MC, et al. Influence of Hesperidin on the Systemic and Intestinal Rat
Immune Response. J nutrients MDPI. 2017; vol 9 (580) : 1-14.

5. Wang X, et al. Effects of Hesperidin on the Progression of Hypercholesterolemia


and Fatty Liver Induced by High-Cholesterol Diet in Rats. J Pharmacol. 2011;
Vol.117: 129-138.

6. Somasundaram I. Formulation and evaluation of hesperidin-loaded chitosan


nanosuspension for brain targeting. Journal Drug Invention Today 2018 ;Vol 10
(3) : 279-283.

7. Anwer M, Al-Shdefat, Jamil S, Solubility of Bioactive Compound Hesperidin in


Six Pure Solvents at (298.15 to 333.15) K . J. Chem. Eng. 2014; Vol 59:
2065−2069.

8. Varghese JJ, Mallya R. Formulation Development and Evaluation of Antioxidant


Potential of Hesperidin Nanocrystals. WJPR.2015; Vol 4(8) : 1149-1170.

9. Meng F, Chauhan H, Gala U. Classification of Solid Dispersions : Correlation to


(i) Stability and Solubility (II) Preparation and Characterization Techniques.
DDIP. 2015; Vol 41 (9) :1401-1415.
31

10. Abdou, HM. Dissolution Bioavailability and Bioeqivalence. Pennsylvania : Marc


Printing Company. 1989. p 11-2, 60-2, 257-77.

11. Singh S, Baghel RS, Yadav L. A Review on Solid Dispersion. IJPL. 2013; Vol. 2
(9) : 1078-1095.

12. Shid RL, Dhole SN, Kulkarni N, Shid SL. Nanosuspension: A Review. Int. J.
Pharm. Sci. Rev. Res. 2013; Vol 22(1) : 98-106

13. Saragih Y, Sofian I. Perbedaan Metode Pembuatan Obat Dengan Sistem Dispersi
Padat : Review Artikel. Farmaka, 2014; 14(3): 37-50

14. Farhan AB, et al. An investigation into the factor governing the degree of
dissolution enchancement of solid dispersion for poorly soluble drugs. JAMR.
2016 ; Vol 1(4)

15. Kumar B, Solid Dispersion- A Review. Pharmatutor. 2014; 5(2): 25-30

16. Mahmoudi ZN, Upadhye SB, Ferrizzi D, et al. In Vitro Characterization of a


Novel Polymeric System for Preparation of Amorphous Solid Drug Dispersions.
The AAPS Journal, 2014; Vol. 16 (4)

17. Chen Y, et al. Initial Drug Dissolution from Amorphous Solid Dispersions
Controlled by Polymer Dissolution and Drug-Polymer Interaction. J Pharm Res.
2016.

18. Howlader, et al. Enchancing dissolution profile of Diazepam using Hydrophilic


Polymers by Solid Dispersion Technique. International Current Pharmaceutical
Journal, 1(12) : 423-430.

19. Zaini E, Novitasari N, Octavia MD. Pembentukan Sistem Dispersi Padat Amorf
Azitromisin Dihidrat dengan Hikroksipropil Metilselulosa (HPMC). Jurnal Sains
Farmasi & Klinis. 2017;3(2) : 165-171
32

20. Alatas, F., Nurono, S., Asyarie, S., Pengaruh konsentrasi PEG 4000 terhadap laju
disolusi ketoprofen dalam sistem dispersi padat ketoprofen-PEG 4000. Dalam
Maj. Farm. Indonesia. Fak. Farm. UJAY Dan ITB. 2006 : 57–62.

21. Wardiyah, Asyarie S, Wikarsa S. Pembuatan dan Karakterisasi Dispersi Padat


Sistem Biner dan Terner dari Gliklazid. Acta Pharmaceutica Indonesia. 2012 ;
Vol. 37 (3) :90- 95

22. Kalepu, S., & Nekkanti, V. Insoluble drug delivery strategies: review of recent
advances and business prospects. Acta Pharmaceutica Sinica B. 2015 ;5(5): 442-
453

23. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients sixth
edition Hypromellose. Pharmaceutical Press. 2008: 346-328.

24. LaFountaine JS, et al. Thermal Processing of PVP- and HPMC-Based


Amorphous Solid Dispersions. AAPS PharmSciTech. 2016 ; Vol 17(1) : 121-
131.

25. Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and
poor permeability. Journal of pharmacological and toxicological methods, 44(1),
235-249.

26. Martin, Alfred et al. Dasar - dasar Farmasi Fisik Dalam Ilmu Farmasetik . Jakarta
2008: UI Press

27. Gaikwad SS, Mhalaskar RS, Mahale YD, Jain NP. Review On: Solubility
Enhancement Of Poorly Water Soluble Drug. IAJPR. 2014 ; Vol. 4(11) : 5530-
5540

28. Dirjen POM. Farmakope Indonesia. Edisi Keempat. Jakarta: Departemen


Kesehatan RI. 1995 : 461,1022,1084.

29. Mazzaferro LS, Breccia JD. Quantification of hesperidin in citrus-based foods


using a fungal diglycosidase. Food Chem. 2012; 134(4):2338-44
33

30. Jeffry YH. Preparasi Dan Karakterisasi Submikro Partikel Poly (Lactic-Co-
Glycolic Acid) Pembawa Azitromisin Dengan Stabilizer Poly (Vinyl Alcohol).
[Skripsi]. Inderalaya: Fakultas MIPA, Program Studi Farmasi,Universitas
Sriwijaya. 2016 :39,68

31. Vimalson DC, Parimalakrishnan S, Jeganathan NS, Anbazhagan S. Techniques


to Enhance Solubility of Hydrophobic Drugs: An Overview. Asian Journal of
Pharmaceutics. 2016 ; Vol. 10(2) : 68-74

32. Naveen P, Harish M., Rajendar CR. Raghu A, Kumar R. Review On Dissolution
Testing For Pharmaceutical Dosage Forms. IJIPSR. 2013 ; Vol 1 (2) : 206- 226

33. Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble


drugs by solid dispersion. International Journal of Pharmaceutical Investigation.
2012 ; Vol 2(1): 12-17

34. Sansone F, Rossi A, Del Gaudio P, De Simone F, Aquino RP, Lauro MR.
Hesperidin Gastroresistant Microparticles by Spray-Drying: Preparation,
Characterization, and Dissolution Profiles. AAPS PharmSciTech.
2009;10(2):391–401.

35. Hosnaningmulya GA, Fahrurroji A, Riza H. Design And Evaluation Of


Hesperidin Microemulsion-Loaded Hydrogel For Topical Delivery.[Skripsi].
Pontianak : Fakultas Kedokteran. Program Studi Farmasi. 2017. P 22,23

36. Nikghalb LA, Singh G, Kahkeshan KF. Solid Dispersion: Methods and Polymers
to increase the solubility of poorly soluble drugs. Journal of Applied
Pharmaceutical Science. 2012 ; Vol 2 (10) : 170 – 175

37. Kementerian Kesehatan Republik Indonesia. Farmakope Indonesia : Edisi V.


Kemenkes RI, Jakarta. 2014.p 1688

38. Srilatha D, Nasare M, Nagasandhya B, Prasad V, Diwan P. Development and


Validation of UV Spectrophotometric Method for Simultaneous Estimation of
Hesperidin and Diosmin in the Pharmaceutical Dosage Form [Internet].
International Scholarly Research Notices. 2013 [dicitasi 1 November 2018]
34

39. Hyunh-Ba K. Handbook of Stability Testing in Pharmaceutical Development :


Regulation, Methodologies, and Best Practice. New York: Springer; 2008

40. Caze J. Erwing’s Analytical Instrumentation Handbook. third edition. NewYork:


Marcel Dekker; 2005

41. Riyanto, Validasi & Verifikasi Metode Uji: Sesuai dengan ISO/IEC 17025
Laboratorium Pengujian dan Kalibrasi. Yogyakarta: Deepublish; 2014

42. Vora C, Patadia R, Mittal K, Mashru R. Preparation and characterization of


dipyridamole solid dispersions for stabilization of supersaturation: effect of
precipitation inhibitors type and molecular weight. Pharm Dev Technol, Early
Online: 1–9

43. Afriyanti I. Pembentukan Dispersi Padat Asam Usnat-Hpmc 2910 Dengan


Teknik Spray Drying. [Skripsi]. Padang : Universitas Andalas. Fakultas Farmasi.
p 44.

44. Wardiyah, Asyarie S, Wikarsa S. Pembuatan dan Karakterisasi Dispersi Padat


Sistem Biner dan Terner dari Gliklazid. Acta Pharmaceutica Indonesia. 2012;
Vol 37(3): 95-99

45. Kanaze FI, Kokkalou E, Niopas I, Georgarakis M, Stergiou A. Bikiaris D.


Dissolution Enhancement of Flavonoids by Solid Dispersion in PVP and PEG
Matrixes: A Comparative Study. 2006 ; Vol. 102: 460–471

46. Rahayu WS, Utami PI, Fajar SI. Penetapan Kadar Tablet Ranitidin
Menggunakan Metode Spektrofotometri Uv-Vis Dengan Pelarut Metanol.
Pharmacy. 2009 ; Vol.06 (03): 1-11

47. Sirait RA. Penetapan metode spektrofotometri ultraviolet pada penetapan kadar
nifedipin dalam sediaan tablet [Skripsi]. Medan: Universitas Sumatera Utara;
2009.
35

48. Siswanto A , Hapsari I, Zulaikha YU, Rosmawati E. Pemodelan Pelepasan In


Vitro Tablet Floating Teofilin Dengan Program DDsolver. Pharmacy. 2016 :
Vol.13 (01) :30-41

49. Mohamad NI, Nuwarda RF. Review: Variasi Metode Uji Disolusi Terbanding
(UDT). Farmaka Suplemen. 2017; Vol.15 (1) :30-39

50. Pertiwi H. Evaluasi Profil Disolusi Tablet Lepas Lambat Teofilin yang Beredar
di Masyarakat.[Skripsi]. UIN Syarif Hidayatullah Jakarta. Fakultas Kedokteran
dan Ilmu Kesehatan. 2015. P 15-20

51. Ganesan P, Soundararajan R, Shanmugam U, Ramu V. Development,


characterization and solubility enhancement of comparative dissolution study of
second generation of solid dispersions and microspheres for poorly water soluble
drug. AJPS. 2015; Vol. 10 :433-441.

52. Dhiman S, Kaur P, Arora S. Solid Dispersions: Opportunity in Drug Delivery


System. J Drug Invention Today. 2012 ; Vol 4(10):478-486.

53. Garima, B., Vipinp, G. & Siddiqui, MD.N. 2013, Investigation of polymers
alone and in combination for the development of oral thin film, IJPS, India,
1(3):231-235.

54. Cao R, Zhao Y, Zhou Z, Zhao X. Enhancement of the water solubility and
antioxidant activity of hesperidin by chitooligosaccharide. J Sci Food Agric.
2018;Vol 98 (6) : 2422-2427

You might also like